201 related articles for article (PubMed ID: 26539004)
21. Decision-making impairments in breast cancer patients treated with tamoxifen.
Chen X; Li J; Chen J; Li D; Ye R; Zhang J; Zhu C; Tian Y; Wang K
Horm Behav; 2014 Jul; 66(2):449-56. PubMed ID: 25036869
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
23. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
24. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
25. The effect of tamoxifen on the endometrium.
Barakat RR
Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096
[TBL] [Abstract][Full Text] [Related]
26. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound, tamoxifen and endometrial carcinoma.
Ghirardini G; Bianchini A; Rossi GP
Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
[No Abstract] [Full Text] [Related]
28. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
[TBL] [Abstract][Full Text] [Related]
29. [Endometrial cancers arising in polyps associated with tamoxifen use].
Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
Robinson DC; Bloss JD; Schiano MA
Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
32. Gynecologic surveillance of women on tamoxifen: first do no harm.
Runowicz CD
J Clin Oncol; 2000 Oct; 18(20):3457-8. PubMed ID: 11032584
[No Abstract] [Full Text] [Related]
33. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
34. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and risk of endometrial cancer.
Dickson MJ; Pandiarajan T
Lancet; 2001 Jan; 357(9249):67-8. PubMed ID: 11197380
[No Abstract] [Full Text] [Related]
36. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
37. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
38. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
[TBL] [Abstract][Full Text] [Related]
39. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.
Love CD; Muir BB; Scrimgeour JB; Leonard RC; Dillon P; Dixon JM
J Clin Oncol; 1999 Jul; 17(7):2050-4. PubMed ID: 10561257
[TBL] [Abstract][Full Text] [Related]
40. Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
Fisher B
J Clin Oncol; 1996 Mar; 14(3):1027-39. PubMed ID: 8622007
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
